Article Aug 5, 2025 Advancing Celiac Disease Clinical Trials Why Standardized Trial Design Is Critical for Patient Outcomes With over 1% of the global population affected by celiac disease, the necessity for efficacious pharmacological… Read Now
News Aug 5, 2025 Alimentiv and PathwaysGI Partner to bring AI-Based Cumulative Disease Score (CDS) to Ulcerative Colitis Trials PGI’s innovative AI software solution provides secondary analysis of endoscopy videos to maximize the value of UC clinical trial insights London, Ontario, Canada, August 5,… Read Now
News May 3, 2025 Alimentiv Partners with Image Analysis Group to Offer Best-in-Class AI Solution in Histology Endpoints for GI Drug Development A strategic alliance combining full-service clinical trial expertise with cutting-edge imaging analysis technology to accelerate precision medicine in gastroenterology London, Canada, May 3, 2025 – Alimentiv, a… Read Now
News May 1, 2025 Alimentiv and Dova Health Intelligence (Previously Satisfai Health Inc.) Launch an AI Solution for Scoring of Ulcerative Colitis (UC) at DDW 2025 in San Diego Dova’s advanced AI co-pilot, DovaVision ™, is an endoscopy reading tool for UC clinical trials that reveals and quantifies nuanced disease severity for actionable insights… Read Now
News Apr 23, 2025 Alimentiv Experts Share Latest Advancements in GI Clinical Trials at DDW 2025 April 23, 2025 – Alimentiv Inc. (“Alimentiv”) is pleased to announce its participation in the highly anticipated Digestive Disease Week (DDW), taking place May 3–6,… Read Now
News Feb 11, 2025 Alimentiv to Present Key Insights Into GI Research With Multiple Presentations and Posters at the 20th ECCO Congress February 12, 2025 – Alimentiv Inc. (“Alimentiv”) is pleased to announce multiple presentations and posters at the 20th Congress of ECCO (European Crohn’s and Colitis… Read Now
